OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Highlights from WCLC 2026

1 in 4 UK Royal Cancer Stories Contained Alarming Misinformation, Study Finds

Immunõ 2026: Where Is Cancer Immunotherapy Heading Next?

Santiago Millan and Anjali Srivastava։ WHO’s First-Ever Prequalification EOI for Childhood Cancer Medicines

Cesaltina Lorenzoni: Grateful for National Recognition of Oncology Advancements in Mozambique

Chiaojung Jillian Tsai: The CURB2 Trial and the Next Question in Oligoprogressive NSCLC

Yüksel Ürün at COGC 2026: Approval Creates Possibility, Access Creates Impact

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Calculators

Khorana Score (Cancer-Associated VTE Risk)

Estimates venous thromboembolism (VTE) risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points

Our calculators apply published formulas as precisely as we can. Even so, no formula captures every detail of a real patient. Use the result as one input to your own assessment, not the final word.